United States · Markets & Finance · Morningstar

CC Class Action Notice: Chemours Sued for Securities Fraud After Opteon Demand Issues Lead to 18% Stock Drop – Investors Urged to Contact BFA Law by December 7 Deadline

Published by Morningstar · United States 8 h ago

Chemours has been sued for securities fraud after its stock plummeted 18.63% because Chemours allegedly misrepresented the strength of demand for its Opteon products. Leading…

Read the full article on Morningstar Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.morningstar.com)

Also worth reading

Seeking Alpha

NY Fed's Williams sees one more rate hike this year, none in 2027

Decrypt

Bitcoin Whale That Sat Through Every Crash Since 2020 Just Moved $377M

Quartz

FDA advisers are voting on Grail's multicancer blood test as Medicare coverage hangs in the balance

Cointelegraph

Here’s what happened in crypto today

Business Insider

It pays to switch jobs again, but not everyone has that luxury

NYT Business